117 related articles for article (PubMed ID: 16613851)
1. MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.
Collins HM; Kindle KB; Matsuda S; Ryan C; Troke PJF; Kalkhoven E; Heery DM
J Biol Chem; 2006 Jun; 281(25):17124-17133. PubMed ID: 16613851
[TBL] [Abstract][Full Text] [Related]
2. MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.
Kindle KB; Troke PJ; Collins HM; Matsuda S; Bossi D; Bellodi C; Kalkhoven E; Salomoni P; Pelicci PG; Minucci S; Heery DM
Mol Cell Biol; 2005 Feb; 25(3):988-1002. PubMed ID: 15657427
[TBL] [Abstract][Full Text] [Related]
3. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
Yin H; Glass J; Blanchard KL
Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
[TBL] [Abstract][Full Text] [Related]
4. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
[TBL] [Abstract][Full Text] [Related]
5. MOZ-TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2.
Kindle KB; Collins HM; Heery DM
Leukemia; 2010 Jul; 24(7):1359-61. PubMed ID: 20485379
[No Abstract] [Full Text] [Related]
6. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.
Kitabayashi I; Aikawa Y; Nguyen LA; Yokoyama A; Ohki M
EMBO J; 2001 Dec; 20(24):7184-96. PubMed ID: 11742995
[TBL] [Abstract][Full Text] [Related]
7. MOZ and MOZ-CBP cooperate with NF-kappaB to activate transcription from NF-kappaB-dependent promoters.
Chan EM; Chan RJ; Comer EM; Goulet RJ; Crean CD; Brown ZD; Fruehwald AM; Yang Z; Boswell HS; Nakshatri H; Gabig TG
Exp Hematol; 2007 Dec; 35(12):1782-92. PubMed ID: 17920756
[TBL] [Abstract][Full Text] [Related]
8. MOZ fusion proteins in acute myeloid leukaemia.
Troke PJ; Kindle KB; Collins HM; Heery DM
Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
[TBL] [Abstract][Full Text] [Related]
9. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
Carapeti M; Aguiar RC; Goldman JM; Cross NC
Blood; 1998 May; 91(9):3127-33. PubMed ID: 9558366
[TBL] [Abstract][Full Text] [Related]
10. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
[TBL] [Abstract][Full Text] [Related]
11. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
12. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.
Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G
Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485
[TBL] [Abstract][Full Text] [Related]
13. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
[TBL] [Abstract][Full Text] [Related]
14. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
Aikawa Y; Katsumoto T; Zhang P; Shima H; Shino M; Terui K; Ito E; Ohno H; Stanley ER; Singh H; Tenen DG; Kitabayashi I
Nat Med; 2010 May; 16(5):580-5, 1p following 585. PubMed ID: 20418886
[TBL] [Abstract][Full Text] [Related]
15. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
Katsumoto T; Yoshida N; Kitabayashi I
Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
[TBL] [Abstract][Full Text] [Related]
16. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells.
Su M; Bansal AK; Mantovani R; Sodek J
J Biol Chem; 2005 Nov; 280(46):38365-75. PubMed ID: 16087680
[TBL] [Abstract][Full Text] [Related]
18. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
19. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
Tam WF; Hähnel PS; Schüler A; Lee BH; Okabe R; Zhu N; Pante SV; Raffel G; Mercher T; Wernig G; Bockamp E; Sasca D; Kreft A; Robinson GW; Hennighausen L; Gilliland DG; Kindler T
Cancer Res; 2013 Jan; 73(1):373-84. PubMed ID: 23149921
[TBL] [Abstract][Full Text] [Related]
20. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]